You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PLOS this week: genetic characterization of lager yeast, phylogenetic study of Rickettsia africae, and more.
The deal gives Oxford access to Imugen’s Lyme disease tests as well as PCR and immunoassay tests.
The firm expands its portfolio, providing customers with Dx for multiple applications
The test, which uses melt curve analysis and runs on a fully integrated platform from Zeesan, may have a head start on MDR and XDR tests from other companies.
Two Stanford professors are turning to the online game EteRNA to develop a new way to diagnose tuberculosis.
In PLOS this week: founder mutation linked to some leukoencephalopathy cases, transcript and protein profiles of the kissing bug, and more.
A team in Spain used enhanced primer design, magnetic separation, and electrochemical detection to build a TB test as specific and sensitive as PCR.
The firm is using CMOS technology to develop a rapid TB test and other infectious disease panels, and is also partnering with other companies to enable tests.
In Nature this week: researchers uncover 13 healthy people who harbor Mendelian disease mutations, new tree of life, and more.
Researchers discussed using WGS to predict antibacterial resistance, to inform influenza vaccine development, and to diagnose and build drug resistance profiles for tuberculosis.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.